Abstract
44007 Risankizumab Long-Term Safety in Patients With Psoriatic Disease: Integrated Interval Analyses From Psoriasis and Psoriatic Arthritis Clinical Trials
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have